Clin Oncol | Volume 2, Issue 1 | Editorial | Open Access
Alejandro Roisman and Irma Slavutsky*
Laboratory of Genetics of Lymphoid Neoplasms, Institute of Experimental Medicine, Argentina
*Correspondance to: Irma SlavutskyFulltext PDF
MicroRNAs (miRNAs) are short, endogenous singled-stranded noncoding RNAs whose dysregulation has been implicated in important biologic processes, including cancer development. The principal mechanism of action of these master regulators is to control gene expression by suppressing mRNA translation and reducing mRNA stability. In particular, the miR-17-92 cluster is one of the most frequently miRNA expressed in different subtypes of non-Hodgkin lymphomas. Its widespread dysregulation in these pathologies suggests this cluster as a new biomarker that may supplement lymphoma diagnosis and prognosis, and also as an attractive target to design novel strategies for cancer therapy.
Roisman A, Slavutsky I. Mir- 17-92 Cluster Dysregulation in Lymphoid Malignancies: Its Role in Limphomagenesis. Clin Oncol. 2017; 2: 1210.